Levamisole Pellets

(Product under development)
Levamisole PelletsLevamisole (marketed as the hydrochloride salt under the trade name Ergamisol) is an anthelminthic and immunomodulator belonging to a class of synthetic imidazothiazole derivatives.

Levamisole has been used in humans to treat parasitic worm infections, and has been studied in combination with other forms of chemotherapy for colon cancer, melanoma, and head and neck cancer. The drug was withdrawn from the U.S. and Canadian markets in 2000 and 2003 respectively, due to the risk of serious side effects and the availability of more effective replacement medications.

Currently, levamisole remains in veterinary use as a dewormer for livestock. The medication has also been increasingly used as an adulterant in cocaine sold in the U.S. and Canada, resulting in serious side effects.

Availble Form:
Levamisole Pellets
Levamisole Granules

Umang Pharmatech equipments used for production of Levamisole Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Levamisole Pellets
Systematic (IUPAC) Name
Levamisole Pellets
Levamisole Pellets
Chemical data
CAS number : 14769-73-4
ATC code : P02CE01 QP52AE01
PubChem : CID 26879
DrugBank : APRD01067
ChemSpider : 25037
UNII : 2880D3468G
KEGG : D08114
Formula : C11H12N2S
Mol. mass : 204.292 g/mol

* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech